DePuy Synthes (Johnson & Johnson) Acquires CrossRoads Extremity Systems from HealthpointCapital
February 10, 2022
DePuy Synthes, the orthopaedics business of Johnson & Johnson, has acquired CrossRoads Extremity Systems, a Memphis-based designer and manufacturer of procedure-specific implants and instruments for foot and ankle surgery. The seller was HealthpointCapital (with long-time investor MB Venture Partners involved); HealthpointCapital had acquired a majority stake in CrossRoads in May 2019 and executed product and commercial expansion before the sale.
- Buyers
- DePuy Synthes (Johnson & Johnson)
- Targets
- CrossRoads Extremity Systems
- Sellers
- HealthpointCapital Management LLC, MB Venture Partners
- Industry
- Medical Devices
- Location
- Tennessee, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
DePuy Synthes Acquires Expanding Innovations, Inc.
July 17, 2026
Medical Devices
DePuy Synthes, the orthopedics division of Johnson & Johnson MedTech, acquired Expanding Innovations, Inc., a commercial-stage medical technology company focused on expandable interbody cage systems for spine surgery. The acquisition adds proprietary non-screw-based expandable cage technology to strengthen DePuy Synthes’ spine implant portfolio in the lumbar fusion market.
-
Johnson & Johnson Acquires Atraverse Medical
May 28, 2026
Medical Devices
Johnson & Johnson acquired Atraverse Medical, strengthening its J&J MedTech cardiac electrophysiology portfolio. The acquisition follows the May 15, 2026 close and is referenced in connection with medtech founder John Slump’s subsequent launch of Metis MedTech.
-
Acumed Acquires ExsoMed to Expand Upper Extremity Device Portfolio
July 6, 2022
Medical Devices
Acumed, a Colson Medical | Marmon | Berkshire Hathaway company, has acquired ExsoMed, a developer of minimally invasive intramedullary fixation devices for hand surgery. The acquisition adds ExsoMed’s threaded nails and related products to Acumed’s portfolio to broaden its minimally invasive and upper-extremity treatment offerings.
-
Onkos Surgical Acquires the Juvenile Tumour System (JTS) from Stryker
June 13, 2022
Medical Devices
Onkos Surgical entered into a definitive agreement to acquire the Juvenile Tumour System (JTS) extendible prosthesis from Stryker. The device enables non‑invasive implant lengthening for pediatric bone cancer and limb reconstruction cases, and the acquisition expands Onkos's musculoskeletal oncology product portfolio and clinical capabilities.
-
HealthpointCapital-backed CrossRoads Acquires Surgical Frontiers' Implant Systems
November 25, 2019
Medical Devices
HealthpointCapital’s Fund IV portfolio company, CrossRoads Extremity Systems, completed an add-on acquisition of multiple FDA-cleared implant and soft-tissue repair technology assets from Surgical Frontiers LLC, including the KATOR, OsteoPrecise, SpeedButton and Metrics product families. The purchase, which includes issued and pending U.S. patents, strengthens CrossRoads’ extremities product portfolio and supports cross-selling and capability expansion as part of HealthpointCapital’s strategy to build a market-leading orthopedic extremities platform.
-
HealthpointCapital Acquires Controlling Stake in CrossRoads Extremity Systems
May 14, 2019
Medical Devices
HealthpointCapital has acquired a controlling (majority) stake in CrossRoads Extremity Systems, a Memphis-based developer and manufacturer of foot & ankle implants, procedure-specific sterile-packed instrumentation, and the EcoSMART instrument recovery service. HealthpointCapital will partner with CrossRoads' co-founders and management, providing additional equity to fund organic growth, expand the company's portfolio and market presence, and pursue bolt-on acquisitions.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.